Chemerin, a novel adipokine in the regulation of angiogenesis

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 5, 2010, Pages 2476-2485

  Bozaoglu, Kiymet ^a   Curran, Joanne E ^b   Stocker, Claire J ^c   Zaibi, Mohamed S ^c   Segal, David ^a   Konstantopoulos, Nicky ^a   Morrison, Shona ^a   Carless, Melanie ^b   Dyer, Thomas D ^b   Cole, Shelley A ^b   Goring, Harald H H ^b   Moses, Eric K ^b   Walder, Ken ^a   Cawthorne, Michael A ^c   Blangero, John ^b   Jowett, Jeremy B M ^d  

^a DEAKIN UNIVERSITY   (Australia)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF BUCKINGHAM   (United Kingdom)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CHEMERIN; DISCOIDIN; EPITHELIAL GROWTH FACTOR; GROWTH FACTOR; RECOMBINANT CYTOKINE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; CD31 ANTIGEN; CHEMERIN, HUMAN; CHEMOKINE; DNA; SURAMIN; VASCULOTROPIN A;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL; CELL ASSAY; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; FEMALE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENOME ANALYSIS; HERITABILITY; HISPANIC; HUMAN; HUMAN CELL; HUMAN GENOME; HUMAN TISSUE; LEYDIG CELL; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE EXPANSION; BLOOD; CARDIOVASCULAR DISEASE; GENETIC VARIABILITY; GENETICS; GENOTYPE; HOMEOSTASIS; METABOLISM; OBESITY; RISK FACTOR;

ANIMALIA;

ANTIGENS, CD31; CARDIOVASCULAR DISEASES; CHEMOKINES; DNA; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HOMEOSTASIS; HUMANS; MEXICAN AMERICANS; NEOVASCULARIZATION, PHYSIOLOGIC; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SURAMIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77952749129     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0042     Document Type: Article

References (44)

1. Wittamer V, Grégoire F, Robberecht P, Vassart G, Communi D, Parmentier M 2004 The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J Biol Chem 279:9956-9962
2. Zabel BA, Allen SJ, Kulig P, Allen JA, Cichy J, Handel TM, Butcher EC2005 Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem 280:34661-34666
3. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, Brézillon S, Tyldesley R, Blanpain C, Detheux M, Mantovani A, Sozzani S, Vassart G, Parmentier M, Communi D 2003 Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 198:977-985
4. Zabel BA, Ohyama T, Zuniga L, Kim JY, Johnston B, Allen SJ, Guido DG, Handel TM, Butcher EC 2006 Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF-β and TLR ligands. Exp Hematol 34:1106-1114
5. Zabel BA, Zuniga L, Ohyama T, Allen SJ, Cichy J, Handel TM, Butcher EC 2006 Chemoattractants, extracellular proteases, and the integrated host defense response. Exp Hematol 34:1021-1032
6. Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J, Hendrick AG, Carlton MB, Greaves DR 2008 Synthetic chemerin-derived peptides suppress inflammation through Chem R 23. J Exp Med 205:767-775
7. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K, Segal D 2007 Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148:4687-4694 (Pubitemid 47481514)
8. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, Muruganandan S, Sinal CJ 2007 Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 282:28175-28188
9. Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, Parmentier M, Sasaki S 2007 Chemerin - a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 362:1013-1018
10. Takahashi M, Takahashi Y, Takahashi K, Zolotaryov FN, Hong KS, Kitazawa R, Iida K, Okimura Y, Kaji H, Kitazawa S, Kasuga M, Chihara K 2008 Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett 582:573-578
11. Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, Comuzzie AG, Mahaney MC, Rainwater DL, VandeBerg JL, MacCluer JW, Collier G, Blangero J, Walder K, Jowett JB 2009 Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab 94:3085-3088
12. Lehrke M, Becker A, Greif M, Stark R, Laubender RP, von Ziegler F, Lebherz C, Tittus J, Reiser M, Becker C, Göke B, Leber AW, Parhofer KG, Broedl UC 2009 Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 161:339-344
13. Stejskal D, Karpisek M, Hanulova Z, Svestak M 2008 Chemerin is an independent marker of the metabolic syndrome in a Caucasian population-a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152:217-221
14. MacCluer JW, Stern MP, Almasy L, Atwood LA, Blangero J, Comuzzie AG, Dyke B, Haffner SM, Henkel RD, Hixson JE, Kammerer CM, Mahaney MC, Mitchell BD, Rainwater DL, Samollow PB, Sharp RM, VandeBerg JL, Williams JT 1999 Genetics of atherosclerosis risk factors in Mexican Americans. Nutr Rev 57:S59-S65
15. Mitchell BD, Almasy LA, Rainwater DL, Schneider JL, Blangero J, Stern MP, MacCluer JW 1999 Diabetes and hypertension in Mexican American families: relation to cardiovascular risk. Am J Epidemiol 149:1047-1056 (Pubitemid 29246870)
16. Göring HH, Curran JE, Johnson MP, Dyer TD, Charlesworth J, Cole SA, Jowett JB, Abraham LJ, Rainwater DL, Comuzzie AG, Mahaney MC, Almasy L, MacCluer JW, Kissebah AH, Collier GR, Moses EK, Blangero J 2007 Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nat Genet 39:1208-1216
17. Blangero J, Goring HH, Kent Jr JW, Williams JT, Peterson CP, Almasy L, Dyer TD 2005 Quantitative trait nucleotide analysis using Bayesian model selection. Hum Biol 77:541-559
18. Havill LM, Dyer TD, Richardson DK, Mahaney MC, Blangero J 2005 The quantitative trait linkage disequilibrium test: a more powerful alternative to the quantitative transmission disequilibrium test for use in the absence of population stratification. BMC Genet 6(Suppl 1):S91
19. Almasy L, Blangero J 1998 Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211
20. Heath SC 1997 Markov chain Monte Carlo segregation and linkage analysis for oligogenic models. Am J Hum Genet 61:748-760 (Pubitemid 27418415)
21. Boerwinkle E, Chakraborty R, Sing CF 1986 The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann Hum Genet 50:181-194 (Pubitemid 16116788)
22. Li J, Ji L 2005 Adjusting multiple testing in multilocus analyses using the eigen values of a correlation matrix. Heredity 95:221-227
23. Nyholt DR 2004 A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765-769
24. Koizumi K, Tsutsumi Y, Yoshioka Y, Watanabe M, Okamoto T, Mukai Y, Nakagawa S, Mayumi T 2003 Anti-angiogenic effects of dimethyl sulfoxide on endothelial cells. Biol Pharm Bull 26:1295-1298
25. Crews CM, Alessandrini A, Erikson RL 1992 The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 258:478-480
26. Rosen LB, Ginty DD, Weber MJ, Greenberg ME 1994 Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras. Neuron 12:1207-1221
27. Aoka Y, Johnson FL, Penta K, Hirata Ki K, Hidai C, Schatzman R, Varner JA, Quertermous T 2002 The embryonic angiogenic factor Del1 accelerates tumor growth by enhancing vascular formation. Microvasc Res 64:148-161
28. Ho HK, Jang JJ, Kaji S, Spektor G, Fong A, Yang P, Hu BS, Schatzman R, Quertermous T, Cooke JP 2004 Developmental endothelial locus-1 (Del-1), a novel angiogenic protein: its role in ischemia. Circulation 109:1314-1319
29. Penta K, Varner JA, Liaw L, Hidai C, Schatzman R, Quertermous T 1999 Del1 induces integrin signaling and angiogenesis by ligation of αVβ3. J Biol Chem 274:11101-11109 (Pubitemid 129528319)
30. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR 1995 PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494
31. Friedman JM 2000 Obesity in the new millennium. Nature 404:632-634
32. Roth J, Qiang X, Marban SL, Redelt H, Lowell BC 2004 The obesity pandemic: where have we been and where are we going? Obes Res 12(Suppl 2):88S-101S
33. Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W 2004 Reversal of obesity by targeted ablation of adipose tissue. Nat Med 10:625-632
34. Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, Folkman MJ 2002 Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 99:10730-10735
35. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW 2004 Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145:2273-2282
36. Silha JV, Krsek M, Sucharda P, Murphy LJ 2005 Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond) 29:1308-1314
37. Kaur J, Adya R, Tan BK, Chen J, Randeva HS 2010 Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem Biophys Res Commun 391:1762-1768
38. Bouloumie A, Lolmede K, Sengenes C, Galitzky J, Lafontan M 2002 Angiogenesis in adipose tissue. Ann Endocrinol (Paris) 63:91-95
39. Wood IS, de Heredia FP, Wang B, Trayhurn P 2009 Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc:1-8
40. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M, Shimomura I 2007 Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56:901-911
41. Wang B, Wood IS, Trayhurn P 2007 Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 455:479-492 (Pubitemid 47624196)
42. Ye J, Gao Z, Yin J, He Q 2007 Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293:E1118-E1128
43. Lorincz AM, Sukumar S 2006 Molecular links between obesity and breast cancer. Endocr Relat Cancer 13:279-292 (Pubitemid 43886659)
44. Perrier S, Caldefie-Chézet F, Vasson MP 2009 IL-1 family in breast cancer: potential interplay with leptin and other adipocytokines. FEBS Lett 583:259-265